UNSPSC 51351804: Estrogens conjugated

This classification denotes a therapeutic progestin with the molecular formula C18H21NaO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IU5QR144QX but generally known as conjugated estrogens, which bears US NIH Compound Identifier 45357473. European Medicines Agency schedules trioxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB36355. SMILES: CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+].

UNSPSC 51351804 Estrogens conjugated is a Commodity code covering specific pharmaceutical products procured by state and local health systems, correctional facilities, and other government-operated medical programs. State and local governments buy conjugated estrogen products through cooperative purchasing agreements and direct pharmaceutical contracts to supply hospitals, clinics, long-term care facilities, and other public health entities. The buying base includes state health departments, multistate cooperative purchasing alliances, counties, and municipalities operating healthcare infrastructure. These agencies typically procure through group purchasing organizations (GPOs) or statewide cooperative vehicles to aggregate volume and negotiate pricing across multiple jurisdictions and purchasing partners.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for participating state and local government facilities across Minnesota and Oregon. The RFP requires manufacturers to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain relationships with at least two of the three wholesalers with chargeback systems in place, and submit detailed product information including NDC codes, SKUs, UPCs, and manufacturing locations. Evaluation is weighted heavily toward price competitiveness (75 percent), with the remainder distributed across fixed pricing compliance, EDI capability, administrative fee agreement, and data format requirements. The contract term spans two years for new vendors with optional extensions, and awarded vendors will be provided to wholesalers by May 15, 2026, with agreements effective July 1, 2026.